The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The MARIANE-trial: Multicenter phase 1b/2 trial testing safety and efficacy of neoadjuvant intradermal ipilimumab and nivolumab in high-risk stage II melanoma.
 
Lotte L. Hoeijmakers
No Relationships to Disclose
 
Anke M.J. Kuijpers
No Relationships to Disclose
 
Bart A. van de Wiel
Employment - BMSi
 
Marta I. Lopez-Yurda
No Relationships to Disclose
 
Elsemieke I Plasmeijer
No Relationships to Disclose
 
Charlotte L. Zuur
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Sanofi/Regeneron (Inst)
 
Hanna C. van der Pol
No Relationships to Disclose
 
Minke W. Lucas
No Relationships to Disclose
 
Jurriaan Romano
No Relationships to Disclose
 
Judith Lijnsvelt
Honoraria - Elekta
 
Alfonsus Johannes Maria van den Eertwegh
Consulting or Advisory Role - Pierre Fabre
Research Funding - Idera (Inst)
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Mathilde Jalving
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Pierre Fabre (Inst)
 
Ellen Kapiteijn
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Delcath Systems (Inst); Immunocore (Inst); Lilly (Inst)
Research Funding - BMS (Inst); Delcath Systems (Inst); Novartis (Inst); Pierre Fabre (Inst)
 
Karijn Suijkerbuijk
Consulting or Advisory Role - Abbvie (Inst); Pierre Fabre (Inst); Sairopa (Inst)
Research Funding - Bristol Myers Squibb Foundation (Inst); Genmab (Inst); Philips Research (Inst); TigaTx (Inst)
 
Astrid Aplonia Maria Van Der Veldt
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Eisai (Inst); Ipsen (Inst); Merck (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst)
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; MSD Oncology; Novartis; Roche; Roche
 
Bart Jacobs
No Relationships to Disclose
 
Tanja D de Gruijl
Stock and Other Ownership Interests - LAVA Therapetics
Consulting or Advisory Role - GE Health (Inst); LAVA Therapeutics (Inst); Mendus (Inst)
Research Funding - Idera Pharmaceuticals (now Aceragen) (Inst)
Patents, Royalties, Other Intellectual Property - Patents on the use of bispecific VHHs for tumor targeting of Vgamma9Vdelta2 T cells
 
Christian U. Blank
Stock and Other Ownership Interests - Immagene; Signature Oncology
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); GenMab (Inst); GlaxoSmithKline (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst); Third Rock Ventures
Research Funding - 4SC (Inst); Bristol-Myers Squibb (Inst); NanoString Technologies (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - WO 2021/177822 A1
Expert Testimony - Freshfields Bruckhaus Deringer
Travel, Accommodations, Expenses - Bristol-Myers Squibb